.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 8,137,657

« Back to Dashboard

Details for Patent: 8,137,657

Title:Carrier particles for use in dry powder inhalers
Abstract: In a method of producing particles suitable for use as carrier particles in dry powder inhalers, particles (1) of a size suitable for use as carrier particles in dry powder inhalers are treated so as to dislodge small grains from the surface of the particles, without substantially changing the size of the particles during the treatment. The treatment gives improved efficiency of redispersion of active particles from the surfaces of carrier particles.
Inventor(s): Staniforth; John Nicholas (Bath, GB)
Assignee: Vectura Limited (Wiltshire, GB)
Filing Date:May 16, 2003
Application Number:10/439,820
Claims:1. A method of producing particles for use as carrier particles in dry powder inhalers, the method comprising the steps of: selecting particles of a pharmacologically inert material or combination of materials, to obtain carrier particles having a diameter of between 50 .mu.m and 1000 .mu.m; milling the selected carrier particles to dislodge small grains from the surfaces of the selected particles without substantially changing the size of the selected carrier particles, wherein the step of selecting the size of the carrier particles occurs prior to the step of milling the selected particles; wherein the milling step is performed in a recirculated low fluid energy mill, and wherein the small grains become reattached to the surfaces of the carrier particles.

2. A method according to claim 1 wherein the particles are crystalline sugar particles.

3. A method according to claim 1 wherein the particles are lactose particles.

4. A method of producing a dry powder for use in dry powder inhalers, the method including producing carrier particles using a method according to claim 1, and mixing the carrier particles with active particles such that the active particles adhere to the surfaces of carrier particles.

5. A method according to claim 4 wherein the diameter of the active particles is between 0.1 .mu.m and 3 .mu.m.

6. A method according to claim 4 wherein the carrier particles and the active particles are mixed in a container made from a plastics material.

7. A method according to claim 4 wherein the carrier particles and the active particles are mixed for at least five minutes.

8. A method according to claim 7 wherein the carrier particles and the active particles are mixed for thirty minutes.

9. A method according to claim 7 wherein the mixing is interrupted and the mixture of carrier particles and active particles is sieved.

10. A method according to claim 9 wherein sieve mesh size is about 250 .mu.m.

11. A method according to claim 4 wherein the carrier particles and the active particles are mixed in a ratio by weight of 125 to 1.

12. A method according to claim 4 wherein the active particles include a .beta..sub.2-agonist.

13. A method according to claim 12 wherein the active particles include terbutaline, a salt of terbutaline or a combination thereof.

14. A method according to claim 12 wherein the active particles include salbutamol, a salt of salbutamol or a combination thereof.

15. A method according to claim 14 wherein the active particles include salbutamol sulphate.

16. A method as claimed in claim 4, wherein the small grains become reattached to the surface of the carrier particles.

17. A method as claimed in claim 1, wherein the small grains become reattached to the surface of the carrier particles in a mixing step that follows the milling step.

18. A method according to claim 3, wherein diameter of the selected particles is less than 355 .mu.m.

19. A method according to claim 3, wherein diameter of the selected particles lies between 60 .mu.m and 250 .mu.m.

20. A method according to claim 3, wherein diameter of the selected particles lies between 90 .mu.m and 250 .mu.m.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc